Antisense oligonucleotides targeting ACTL6B
The present invention relates to antisense oligonucleotide splicing modulators of actin-like 6B (ACTL6B). These antisense oligonucleotide splice modulators are complementary, such as fully complementary, to ACTL6B precursor mRNA, and are capable of increasing or restoring expression of ACTL6B in TDP...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to antisense oligonucleotide splicing modulators of actin-like 6B (ACTL6B). These antisense oligonucleotide splice modulators are complementary, such as fully complementary, to ACTL6B precursor mRNA, and are capable of increasing or restoring expression of ACTL6B in TDP-43 depleted cells, such as for TDP-43 functional depleted conditions and medical indications.
本发明涉及肌动蛋白样6B(ACTL6B)的反义寡核苷酸剪接调节剂。这些反义寡核苷酸剪接调节剂与ACTL6B前体mRNA互补,诸如完全互补,并且能够在TDP-43耗竭的细胞中增加或恢复ACTL6B的表达,诸如用于TDP-43功能耗竭的病况和医学适应症。 |
---|